论文信息 - Evaluation of 8‐week glecaprevir/pibrentasvir treatment in direct‐acting antiviral‐naïve noncirrhotic HCV genotype 1 and 2infected patients in a real‐world setting in Japan - 字舞流文

Evaluation of 8‐week glecaprevir/pibrentasvir treatment in direct‐acting antiviral‐naïve noncirrhotic HCV genotype 1 and 2infected patients in a real‐world setting in Japan

J. Tani | A. Tsubota | Etsuko Iio | Yasuhito Tanaka | K. Iwakiri | H. Toyoda | Tsunekazu Oikawa | S. Tsuruoka | A. Asai | M. Nakamuta | T. Kumada | T. Ikegami | K. Kikuchi | H. Ikeda | A. Hiraoka | S. Fukunishi | Tsunamasa Watanabe | A. Nozaki | N. Matsumoto | C. Okuse | Y. Tachi | T. Tada | S. Mikami | K. Takaguchi | N. Shimada | M. Atsukawa | Keizo Kato | N. Itokawa | H. Uojima | T. Asano | N. Yamashita | Yoshihiro Matsumoto | K. Hayama | C. Kondo | A. Tsutsui | Akio Moriya | H. Okubo | C. Ogawa | T. Arai | Yoshihiko Tachi